BEHANDLUNG EINER NEUROLOGISCHEN ERKRANKUNG MIT KOMPLEMENTINHIBITOREN

European patent · EP4028126 · In force

Register entry

Publication number
EP4028126
Application number
EP20781171
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 11, 2020
Published
Jul 20, 2022
Granted
Feb 26, 2025
Protection ends at the latest
Sep 10, 2040
Next annual fee due
Sep 30, 2027
IPC classes
A61K 38/12 (2006.01)
A61P 21/00 (2006.01)
A61P 21/04 (2006.01)
G01N 33/564 (2006.01)
G01N 33/68 (2006.01)
Priority
US 201962899488 P 12.09.2019
US 202062969742 P 04.02.2020
US 202062988587 P 12.03.2020
US 202063021742 P 08.05.2020
PCT application
PCT/US2020/050422 11.09.2020
PCT publication
WO2021/050885 18.03.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Jan 7, 2026

    Change

    Published in Swissreg on 07.01.2026

  3. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  4. Jun 25, 2025

    Owner

    Owner
    RA Pharmaceuticals, Inc., 87 Cambridge Park Drive, Cambridge, MA 02140, USA → UCB Holdings, Inc., 1950 Lake Park Drive, Smyrna, GA 30080, USA

    Published in Swissreg on 25.06.2025

  5. Feb 26, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.02.2025

Parties

Inventor

READ, Simon J.

Lexington, Massachusetts 02421, US

RICARDO, Alonso

Winchester, Massachusetts 01890, US

SAYEGH, Camil

Belmont, Massachusetts 02478, US

XU, Xiangyang

Auburndale, Massachusetts 02466, US

TANG, Yalan

Cambridge, Massachusetts 02140, US

TANG, Guo-Qing

Acton, Massachusetts 01720, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.